By: IPP Bureau
Last updated : May 16, 2025 12:47 pm
Pharma major Lupin Limited reported its financial performance for the quarter and fiscal year ending March 31, 2025. Based on the long-term outlook the Board has recommended a dividend of 600%.
The company has reported total income of Rs. 5,724.08 crores during the period ended March 31, 2025 as compared to Rs. 5,821.42 crores during the period ended December 31, 2024. The company reported total income of Rs. 4, 990.04 crores during the period ended March 31, 2024.
The company has posted net profit of Rs. 772.52 crores for the period ended March 31, 2025 as against net profit of Rs. 855.16 crores for the period ended December 31, 2024. The company posted net profit of Rs. 359.43 crores for the period ended March 31, 2024.
For the Financial Year ended March 31, 2025, Lupin has reported total income of Rs. 22,903.72 crores as compared to Rs. 20,130.99 crores during the Financial Year ended March 31, 2024.
The company has posted net profit of Rs. 3,281.62 crores for the Financial Year ended March 31, 2025 as against net profit of Rs. 1,914.48 crores for the Financial Year ended March 31, 2024.
Commenting on the results, Nilesh Gupta, Managing Director, Lupin Limited said “We are delighted to end the last quarter and the year on a strong note. FY25 was led by strong growth in Sales and Profitability driven by in-line and new products, and consistent improvement in operating margins backed by strong commercial momentum and operational efficiencies. We are optimistic to continue this momentum in the year ahead.”